Clinical Trial Update: Docetaxel and Cisplatin in Treating Patients With Untreated Stage IIIA Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of docetaxel and cisplatin in previously untreated stage IIIA non-small cell lung cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED